0001415889-23-000726.txt : 20230110
0001415889-23-000726.hdr.sgml : 20230110
20230110162427
ACCESSION NUMBER: 0001415889-23-000726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230106
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferra Joseph J Jr
CENTRAL INDEX KEY: 0001733790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 23521415
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
form4-01102023_090113.xml
X0306
4
2023-01-06
0001783032
Elevation Oncology, Inc.
ELEV
0001733790
Ferra Joseph J Jr
C/O ELEVATION ONCOLOGY, INC.
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
false
true
false
false
INTERIM CEO & CFO
Stock Option (Right to Buy)
0.75
2023-01-06
4
A
0
240000
0
A
2033-01-05
Common Stock
240000
240000
D
Stock Option (Right to Buy)
0.75
2023-01-06
4
A
0
30000
0
A
2033-01-05
Common Stock
30000
30000
D
The stock option vested as to 25% of the total shares on January 6, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
The stock option vests as to 1/6 of the total shares monthly, commencing on February 6, 2023, until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Robert Yang, Attorney-in-Fact
2023-01-10